Nov. 22, 2024
| Today’s news and insights for medtech leaders
The Center for Devices and Radiological Health’s pilot program is meant to cut the time between the FDA’s awareness of potentially high-risk recalls and when the public is notified.
|
Fortimedix develops flexible surgical instruments that are responsive enough to navigate the body and enable endoscopic and minimally invasive procedures.
|
The clearance paves the way for the launch of Medtronic’s Smart MDI system, which combines its InPen and Simplera continuous glucose monitor for people who take multiple daily insulin injections.
|
The increasing cost and effort required to maintain, update or replace legacy systems to comply with current standards means mounting technical debt for medtech. Learn how composable tech can help in
|
Kennedy's views on vaccines in particular are causing alarm among some physicians and investors.
|
Acentus, which specializes in supplying glucose sensors to patients’ homes, continues Henry Schein’s recent focus on building its homecare medical supplies business.
|
Aerosol deposits could accumulate on a sensor and affect oxygen delivery, the FDA said in a recall notice. Several of the ventilator models were previously recalled for separate problems.
|
|
How do you get your medical device past complex trial obstacles and over the finish line? Explore the the tools and strategic planning that can help reduce costs and delays in this playbook.
|
|
From Our Library
Webinar - on demand
Custom content for Avery Dennison
|
Webinar - on demand
Custom content for ORO Labs
|
Survey Report
Custom content for AcuityMD
|
| 
